-
SGI-1027 and Everolimus in Renal Cancer
2026-09-21
A study in Advanced Science identifies SGI-1027 as a methuosis inducer and shows that it cooperates with everolimus to suppress renal cancer through lysosomal membrane permeability, apoptosis, and GSDME-dependent pyroptosis. The findings provide a mechanistic framework for combining mTOR inhibition with noncanonical cell-death pathways to address everolimus resistance.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-21
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines pathogen-associated immune stimuli with metabolic pathway modulation and cytokine measurement. The workflow provides a practical framework for comparing donor responses and examining how metabolic interventions, including mycophenolic acid-related IMPDH inhibition, selectively reshape immune signaling.
-
Biotin-HPDP for Reversible Thiol Labeling
2026-09-20
Biotin-HPDP enables selective labeling of accessible cysteine thiols while preserving a reversible disulfide linkage for affinity capture and release. Its workflow is especially useful for biotin-switch assays, detection of S-nitrosylated proteins, and mechanistic studies of redox-regulated plant stress proteins.
-
Sabutoclax in Reliable Apoptosis Assays
2026-09-19
Learn how Sabutoclax (SKU A4199) can clarify viability, proliferation, and apoptosis results in cancer-cell assays. This scenario-based guide connects pan-Bcl-2 pharmacology with practical stock preparation, controls, data interpretation, and evidence-based product selection.
-
Plerixafor (AMD3100) for CXCR4 Research
2026-09-19
Plerixafor (AMD3100) converts CXCL12/CXCR4 signaling into a controllable variable for cancer migration, stem-cell trafficking, and immune-cell redistribution studies. This practical guide connects compound handling with assay design, comparative benchmarking, troubleshooting, and translational interpretation.
-
Coelenterazine: Choosing the Right ROS Signal
2026-09-18
Coelenterazine is a versatile luminescent enzyme substrate for separating reporter activity from direct reactive oxygen species signals. This guide applies lessons from brain–kidney AVP research to ROS assay design, BRET, oxidative stress measurement, and cancer imaging.
-
Cinoxacin Workflows for UTI Research
2026-09-17
Build reproducible Cinoxacin susceptibility, bactericidal, and resistance assays around its selective activity against susceptible Gram-negative uropathogens. This workflow connects stock preparation, MIC testing, disk diffusion, time-kill experiments, and translational urinary tract infection research while clearly defining limitations against Pseudomonas and Gram-positive organisms.
-
Tomivosertib and the Fasting-to-Tumor Axis
2026-09-17
Tomivosertib is a potent MNK1 inhibitor for dissecting eIF4E phosphorylation, selective translation, and metabolic adaptation. This article translates fasting-to-tumor biology into practical assay decisions for ketogenesis, pancreatic cancer, AML, and glioblastoma research.
-
HIV-1 Nuclear Pore Licensing in Resting T Cells
2026-09-16
The reference study shows that HIV-1 cell–cell spread activates CD4–LCK–CDK1 signalling to remodel nuclear pore complexes and overcome the nuclear-import barrier in resting CD4+ T cells. This mechanism explains why resting T cells can support infection in vivo despite their strong resistance to cell-free virus in vitro, while distinguishing contact-driven permissivity from generalized T-cell activation.
-
Reading Ovarian Redox Biology with DCFH-DA
2026-09-16
Oxidative stress is often treated as a single endpoint, but translational research requires linking redox change to cell fate, pathway activity, and assay context. This article examines how 2,7-Dichlorodihydrofluorescein diacetate, also known as DCFH-DA, can support mechanistic studies of DHEA-induced granulosa-cell injury, while outlining controls, workflow choices, and limitations that matter for drug discovery and ovarian biology.
-
AG-490 (Tyrphostin B42): JAK2/EGFR Research Guide
2026-09-15
AG-490, also called Tyrphostin B42, is a multitarget tyrosine kinase inhibitor used to study JAK2, EGFR, ErbB2, STAT, and MAPK signaling. Its reported activity supports mechanistic cancer research and immunopathological state suppression, but its cross-target profile requires pathway-specific controls.
-
Ethacridine Lactate Monohydrate in Research
2026-09-15
Ethacridine lactate monohydrate is a high-purity aromatic antiseptic reagent identified as 7-ethoxyacridine-3,9-diamine and supplied for scientific research. Its documented solubility and storage profile support controlled microbial inhibition workflows, but the cited YAP-TEAD study does not establish that this compound regulates stem-cell differentiation.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Mechanistic Guide
2026-09-14
Discover how the Annexin V-Cy5/DAPI Apoptosis Kit can function as a mechanistic decision tool rather than a simple endpoint assay. This guide connects phosphatidylserine exposure and membrane integrity with P2RX1-driven apoptosis in Philadelphia chromosome-positive leukemia.
-
Superoxide Dismutase Activity Assay Kit Guide
2026-09-14
The Superoxide Dismutase Activity Assay Kit (SKU K2035) provides a colorimetric way to measure SOD activity in biological fluids through inhibition of WST-1 formazan formation. It is intended for research workflows such as oxidative stress assays, not for diagnosis, treatment decisions, or direct measurement of superoxide concentration.
-
How Near-Death Stress Creates Metastatic States
2026-09-13
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending death experience can enter stable prometastatic states called PAMEs. Their study connects ER stress, PERK–CHOP signaling, GLI and NANOG-associated reprogramming, and paracrine cytokine signaling to the emergence of migratory tumor-cell ecosystems.